ResearcherTokat Gaziosmanpaşa ÜniversitesiActive in the last 2 years

Ercan Çaçan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3487-9493; OpenAlex author ID A5070086845. Sources: OpenAlex.

Their work

Papers: 3 (first author 1, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2024: 1 paper · 2025: 2 papers

Papers 3

Exploring the TRIM15 protein interaction network as a drug target using machine learning in pancreatic cancer. Last author DOI 10.1007/s12672-025-03847-8 ↗
Twist1 Regulates the Immune Checkpoint VISTA and Promotes the Proliferation, Migration and Progression of Pancreatic Cancer Cells. First author DOI 10.1111/jcmm.70586 ↗
Promoter Hypomethylation Upregulates ANXA2 Expression in Pancreatic Cancer and is Associated with Poor Prognosis. Last author DOI 10.1007/s10528-023-10577-5 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kübra Sena Baş Topcu · 2 shared papers, 2025 · strength 0.96
- Paper Twist1 Regulates the Immune Checkpoint VISTA and Promotes the Proliferation, Migration and Progression of Pancreatic Ca… DOI 10.1111/jcmm.70586 ↗
- Paper Exploring the TRIM15 protein interaction network as a drug target using machine learning in pancreatic cancer. DOI 10.1007/s12672-025-03847-8 ↗
Soumaya Menadi · 1 shared paper, 2024 · strength 0.36
- Paper Promoter Hypomethylation Upregulates ANXA2 Expression in Pancreatic Cancer and is Associated with Poor Prognosis. DOI 10.1007/s10528-023-10577-5 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.